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1. Introduction 
Incidences of infectious diseases in marine mammals have been increasing [1]. Among them, 
morbillivirus infection is the greatest threat to marine mammals becuase it has caused mass 
die-offs in several pinniped and cetacean species in the past few decades [2,3]. The genus 
Morbillivirus belongs to the family Paramyxoviridae, and the viruses in this genus have a 
genome consisting of a single piece of negative-stranded RNA, which encodes eight viral 
proteins: a nucleocapsid protein (N); a phosphoprotein (P); two virulence factors (C and V); 
a matrix protein (M); a membrane fusion protein (F); a hemagglutinin binding protein (H); 
and an RNA polymerase (L) [4]. The two viral surface glycoproteins, H and F, play 
important roles during the viral infection of host cells. The H protein is required for viral 
attachment to the host cells, while the F protein mediates membrane fusion with the host 
plasma membrane and enables the entry of the virus.  
Until the discovery of a new mobillivirus in marine mammals in 1988, only four 
morbillivirus species had been identified in land mammals: the measles virus (MV); 
rinderpest virus (RPV); peste des petits ruminants virus (PPRV); and canine distemper virus 
(CDV) [4]. The new morbillivirus was isolated from dead harbor seals (Phoca vitulina) in a 
mass die-off around the Baltic and North Sea coasts and was named phocine distemper 
virus (PDV) [5,6]. Two other new viruses originating in cetaceans were also isolated from 
dead harbor porpoises (Phocoena phocoena) and striped dolphins (Stenella coeruleoalba) and 
were named porpoise morbillivirus (PMV) and dolphin morbillivirus (DMV) [7,8]. Based on 
the similarities of the gene sequences, it was proposed that the cetacean-origin viruses be 
unified as a single species, cetacean morbillivirus (CMV) [9,10].  
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Morbilliviruses propagate primarily in lymphoid tissues and induce acute disease. They are 
usually accompanied by lymphopenia and immunosuppression, which often lead to 
secondary, opportunistic infections in the host. The distemper viruses, CDV and PDV, often 
invade the central nervous systems of their hosts, although acute encephalitis is not 
common in other morbillivirus infections [4]. A notable feature of morbilliviruses is their 
high host specificity. The natural host of MV is humans, but it can also infect monkeys. 
Ruminants are the targets of RPV and PPRV. RPV mainly infects cattle, while PPRV infects 
goats and sheep. Although these viruses have multiple host compatibilities, they induce 
more severe disease in the primary hosts than in others [11,12]. The natural host for CDV is 
dogs, but ferrets (Mustela putorius furo) have been used as an experimental model due to 
their high sensitivity to CDV. Recently, the host range of CDV has been shown to be wider 
than previously thought and expanded to include other wild carnivores, such as Baikal seals 
(Phoca sibirica) or lions (Panthera leo) [13-15]. PDV and CMV have been isolated only from 
seals and cetaceans, respectively. While no morbilliviruses have been isolated from 
sirenians, serologic evidence of exposure to morbillivirus was reported in manatees 
(Trichechus manatus) without showing clinical signs of disease [16,17].  
The cellular receptor of a virus is one of the major determinants of host specificity and tissue 
tropism. The signaling lymphocyte activation molecule (SLAM) has recently been shown to 
be the principal cellular receptor for morbilliviruses in humans, cows, and dogs [18,19]. 
SLAM itself was first discovered in 1995 as a novel receptor molecule involved in T-cell 
activation [20]. It is expressed on various immune cells, such as thymocytes, activated T and 
B cells, mature dendritic cells, macrophages, and platelets [21,22]. SLAM is also a marker for 
the most primitive hematopoetic stem cells [23]. The distribution and function of SLAM are 
consistent with the cell tropism and immunosuppressive nature of morbilliviruses. This 
indicates that the host range of morbillivirus may be explained by key amino acid residues 
of SLAM on the interface with morbillivirus.  
In this chapter, we review morbillivirus infection in marine mammals and its possible 
primary receptor in the host, SLAM. Further, we discuss host–virus specificities based on 
three-dimensional models of SLAM and risk assessment of morbillivirus infection in marine 
mammals. 
2. Morbillivirus infection and its impact on marine mammals 
2.1. Mass die-offs in marine mammals and discovery of new morbilliviruses 
Since the late 1980s, many mass die-offs have been reported around the coasts of Europe 
and the USA (Table 1). Approximately 18,000 harbor seals and several hundred grey seals 
(Halichoerus grypus) were found dead on northern European coasts in 1988–1989. The 
distemper-like gross observations suggested that a morbillivirus could have been the 
causative agent [6]. Detailed serological, virological, and immunohistochemical 
examinations showed that the agent was a new member of the genus Morbillivirus, named 
phocine distemper virus (PDV) [5,24]. In 2002, PDV again killed at least 21,000 seals 
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inhabiting the same locales [25,26]. About the same time as the first outbreak on northern 
European coasts, in 1987–1988 the deaths of approximately 18,000 Baikal seals were reported 
in Lake Baikal which showed clinical signs identical to those reported in European seals 
[13]. However, subsequent genomic characterization revealed that the cause of the mass die-
off of Baikal seals was CDV [27-31]. CDV also induced another mass die-off among Caspian 
seals (Phoca caspica), in which many seals died in 1997 and 2000, near Azerbaijan on the 
western shores of the Caspian Sea [32,33].  
 
Date Site Animal species No. of dead Virus 
1987-1988 USA Atlantic coast Tursiops truncatus >2,500 CMV 
1987-1988 Lake Baikal Phoca sibirica >18,000 CDV 
1988 North & Baltic Sea Phoca vitulina >18,000 PDV 
1990 Mediterrean Sea Stenella coeruleoalba >2,000 CMV 
1993 Mexican Gulf Tursiops truncatus >1,000 CMV 
1997 Caspian Sea Phoca caspica >2,000 CDV 
2000 Caspian Sea Phoca caspica >10,000 CDV 
2002 North & Baltic Sea Phoca vitulina >21,000 PDV 
CMV, cetacean morbillivirus; CDV, canine distemper virus; PDV, phocine distemper virus. 
Table 1. Mass die-offs of marine mammals caused by morbilliviruses. 
The first evidence of morbillivirus infection in cetaceans was described in several stranded 
harbor porpoises with pathological changes on the Irish coastline in 1988 [7]. A new 
morbillivirus was isolated and termed PMV for “porpoise” [34]. Since 1990, a severe mass 
die-off began to affect the striped dolphin (Stenella coeruleoalba) population on the 
Mediterranean coast of Spain and rapidly spread throughout the western Mediterranean 
Sea, including the coasts of France, Italy, Greece, and Turkey [8,35] (Table 1). A new virus, 
named DMV for “dolphin” was isolated as the causative agent [9]. A retrospective serologic 
investigation indicated that PMV and DMV were the agents responsible for another 
epidemic in bottlenose dolphins (Tursiops truncatus) along the Atlantic coast of the USA, for 
which the causative agent had been initially thought to be brevetoxin produced by a marine 
dinoflagellate (Ptychodiscus brevis) [36-38]. PMV also induced a die-off of bottlenose dolphins 
in the Gulf of Mexico during 1993–1994 [37-39]. Molecular biological analyses of these 
cetacean morbilliviruses showed that their gene sequences were similar [9,10]. Based on the 
similarities, it was proposed that these cetacean morbilliviruses be classified as a single 
species called CMV. 
Thus, morbillivirus infection has a strong impact on populations of marine mammals, as 
listed in Table 1. In addition to mass die-offs, many smaller-scale die-offs were reported in 
various oceans. Even if the scale is small, outbreaks of morbillivirus infection can have 
serious consequences for marine mammal populations, especially among endangered 
species at risk of extinction, such as Mediterranean monk seals (Monachus monachus). In 
1997, approximately 50% of the population of Mediterranean monk seals residing along the 
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coast of Mauritania in Africa died suddenly. Morbilliviruses were isolated from the dead 
seals, although distemper-like lesions were not detected in the animals [40]. Hence, it 
remains unclear whether morbillivirus was the agent responsible for the dramatic deaths. 
The involvement of an algal bloom was also suggested as the primary cause [41]. In any 
case, when populations of many marine mammal species are decreasing, morbillivirus 
infection may cause a fatal blow.  
2.2. Transmission and maintenance reservoir of marine morbilliviruses 
The origin, precise mode of transmission, and maintenance reservoir of morbilliviruses 
causing die-off epidemics in marine mammals remain to be elucidated. Morbilliviruses 
proliferate in the infected animal for a short time after infection but do not persist in the host 
[4]. After being shed from the infected host, they do not survive long in the environment [4]. 
For the transmission of morbilliviruses, therefore, close contact between acutely infected and 
susceptible animals is required. In addition, because a morbillivirus infection results in 
lifelong immunity in the infected animal, when the virus is maintained in an animal 
population, a constant supply of new susceptible animals is needed. It has been calculated 
that the minimal population size for MV maintenance is approximately 300,000 individuals 
[42]. In the mass die-off of European seals in 1988, the most likely viral source was an 
infected seal population in the Arctic region, which moved southward and made contact 
with the population on the European coast. This hypothesis was based on the results of 
serologic studies using archival seal sera. PDV-specific antibodies were not observed in 
European seal sera before 1988, indicating that the population was naive and had not been 
previously exposed to the virus [43]. However, specific antibodies were detected in sera 
obtained from arctic seals long before 1998 [44,45]. In addition, alterations in the migration 
patterns of Arctic harp seal (Phoca groenlandica) populations were recorded. They were seen 
much farther south than usual in northern European waters in the year prior to the epizootic 
of the harp seal population [46]. The harp seal population is extremely large, with four 
million individuals in Canadian waters alone, which is sufficient to maintain morbillivirus 
circulating within the population. Subclinically or subacutely affected animals might play an 
important role in the transmission of the virus.  
It should be noted that morbillivirus transmission sometimes occurs between marine and 
land mammals. As described above, the mass die-offs of Baikal seals and Caspian seals were 
caused by infection with CDV [28,30,32]. The most likely source of infection was land 
animals infected with CDV, because outbreaks were common among the numerous feral 
and domestic dogs around the lake [47]. Accidental infection in the opposite direction was 
also reported. A farmed mink population fed infected seal meat was infected with PDV in 
Denmark during the 1988 epizootic of PDV [48].  
3. SLAM, a receptor of morbillivirus 
The characteristics of SLAM have been extensively studied in humans. SLAM (CD150) is a 
type I transmembrane protein, and there are many members of the SLAM family including 
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the well-known 2B4 (CD244), Ly-9 (CD229), NTB-A, and CD84 [49]. All of the SLAM family 
members have an extracellular region composed of a membrane-distal immunoglobulin 
variable (V) domain and a membrane-proximal immunoglobulin constant-2 (C2) domain, 
along with a cytoplasmic region bearing multiple tyrosine-based switch motifs (ITSMs) that 
bind cytoplasmic Src homology-2 (SH2)-containing proteins such as SLAM-associated 
protein (SAP) [50]. Evidence is accumulating that the interaction between the cytoplasmic 
region of SLAM and SAP family molecules mediates a switch to positive or negative 
signaling in immune cells and plays a crucial role in multiple immune regulations [22]. 
Genes for the SLAM family receptors are located within a ~400-kb cluster on chromosome 1 
in humans and mice [51]. This gene location, coupled with the conserved exon-intron 
structure of SLAM-related genes, implies that they were generated by the sequential 
duplication of a single ancestral gene. A SLAM family receptor forms a homophilic dimer by 
weak binding between the V domains and acts as a self-ligand, suggesting that the receptors 
can trigger homotypic or heterotypic cell–cell interactions [52]. The V domain of SLAM 
(CD150) also provides an interface for binding with morbilliviruses [53]. The viral H protein 
has a strong affinity for the V domain of SLAM, which is 400-fold higher than for self-ligand 
interaction [54]. The interaction between the viral H protein and SLAM V domain is the 
initial event in infection with morbilliviruses. The results of recent detailed structural 
studies have suggested that the interaction changes the microenvironment of the interaction 
zone for the fusion activity of the F protein, although the mechanism of membrane fusion 
mediated by the F protein is not fully understood [55-58].  
3.1. History of the discovery of the morbillivirus receptor 
The human CD46 molecule was first identified as a cellular receptor for Edmonston vaccine 
strains of MV [59,60]. The Edmonston strain was isolated from the blood and throat 
washings of a child with measles using primary human kidney cells in 1954 [61]. It was later 
adapted to chick embryo fibroblasts and is being used as an attenuated vaccine [62]. This 
strain grows well in many cell lines, such as Vero cells, and has become the most extensively 
studied MV strain in the laboratory. However, because CD46, a complement-regulatory 
molecule, is expressed on all human nucleated cells, its ubiquitous distribution cannot 
explain the lymphoid tropism of MV. At present, CD46 is thought to be a specific receptor of 
the Edmonston strain, which is presumed to acquire the ability to use CD46 by adapting to 
cultured human kidney cells. 
On the other hand, many wild-type strains have been isolated from clinical samples using 
the marmoset B cell line (B95a) [63], but they do not grow on many CD46+ cell lines. In order 
to identify the receptor for wild-type MV, functional expression cloning of a cDNA library 
of B95a cells was carried out using the VSV pseudotype system. SLAM was shown to be a 
cellular receptor for wild-type MV [18]. CDV and RPV were also shown to use canine and 
bovine SLAMs for entry into host cells [19]. Thus, SLAM is thought to be the major receptor 
for wild-type morbillviruses.  
Recently, Nectin 4, a cellular adhesion junction molecule, has been identified as the third 
receptor for MV in polarized epithelial cells [64,65]. Infection experiments in monkeys 
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showed that MV initially targets SLAM-positive immune cells such as alveolar 
macrophages, dendritic cells, and lymphocytes, and later the viral infection spreads to the 
epithelial cells of the trachea, lungs, oral cavity, pharynx, or intestines, which are SLAM-
negative cells [66,67]. Another infection experiment using epithelial cell receptor-blind MV, 
demonstrated that the mutant MV inoculated intranasally to monkeys shows virulence and 
infectivity toward lymphoid tissues, although the virus cannot cross the airway epithelium 
and cannot be shed in the air [68]. The molecule forms tight junctions on polarized epithelial 
cells and was shown to function as the receptor for effectively releasing MV to the apical 
side of epithelial cells [69,70]. This explains why MV is highly contagious. Thus, the wild-
type MV posesses two types of receptor, SLAM for entry and propagation and Nectin 4 for 
viral release into the air.  
3.2. Structure of SLAMs of marine mammals 
Cetaceans and sirenians have achieved complete adaptation to the aquatic environment and 
spend all of their lives in water. Cetaceans belong to the order Cetartiodactyla, superorder 
Laurasiatheria, and are closely related to hippopotami or ruminants among land animals. 
Sirenians, including dugongs and manatees, are in the order Sirenia, superorder Afrotheria, 
and are evolutionarily related to elephants or hyraxes. Pinnipeds, belonging to the order 
Carnivora, superorder Laurasiatheria, are not completely adapted to the aquatic 
environment and they must deliver and nurse their young on land. This characteristic of 
pinnipeds makes it possible to transmit infectious diseases between aquatic and land 
mammals. To determine the structure of marine mammal SLAMs, we collected blood samples 
from taxonomically different animal groups, i.e., cetaceans, pinnipeds, and sirenians. White 
blood cells were obtained from: two species of cetacean, a Pacific white-sided dolphin 
(Lagenorhynchus obliquidens) and a killer whale (Orcinus orca); two species of pinniped, a 
spotted seal (Phoca largha), and a walrus (Odobenus rosmarus); and a sirenian, a West Indian 
manatee (Trichechus manatus). The blood of an Indian elephant (Elephas maximus bengalensis) 
was also collected. After immune stimulation with phytohemagglutinin, RNAs of the 
leukocytes were extracted. First, the complete nucleotide sequences of the SLAM genes were 
determined. Three-dimensional models were then generated based on the deduced amino acid 
sequences to compare the interface of their SLAM V domains [71]. 
3.2.1. Primary structure of SLAM proteins 
The deduced amino acid sequences of marine mammal and elephant SLAMs indicated that 
they contain 336–339 amino acid residues, inducing six cysteine residues and six potential 
N-linked glycosylation sites (Figure 1). They have two immunoglobulin-like domains, V and 
C2, in the extracellular region, and two ITSM motifs (T-X-Y-X-X-V/I) and one ITSM-like 
sequence in the intracellular region. These molecular features are shared with all reported 
mammalian SLAMs (Figure 1). The cetacean and pinniped SLAMs showed the greatest 
homology with those of artiodactyla (cow and sheep, 84–85% identity at the amino acid 
level) and of dogs (84%), respectively. Manatee SLAM shared the greatest homology with 
that of the elephant (86%) [71].  
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SP: signal peptide, TM: transmembrane region, V: immunoglobulin V-like domain, C2: immunoglobulin C2-like 
domain. Closed squares: ITSM and ITSM-like motifs, The N-linked glycosylation site and cysteine residues are 
indicated by arrows and triangles, respectively. 
Figure 1. Schematic drawings of domain (a) and primary structure (b) of marine mammal SLAMs.  
3.2.2. Phylogenetic analysis based on SLAM and morbillivirus H proteins 
Phylogenetic trees based on SLAM and the morbillivirus H protein were constructed using 
the maximum-likelihood (ML) and Bayesian methods. In the phylogeny of SLAMs (Figure 
2(a)), each taxonomic group, including primates (humans, chimpanzees, rhesus monkeys, 
and marmosets), cetaceans (Pacific white-sided dolphins and killer whales), artiodactyls 
(cows, buffalo, sheep, and goats), pinnipeds (spotted seals and walruses), and rodents (mice 
and rats), was monophyletic with a 100% ML bootstrap probability (BP) and a 1.00 Bayesian 
posterior probability (BPP). Manatee and elephant SLAMs, dog and pinipped SLAMs, and 
cetacean and artiodactyl SLAMs formed single clades, each with a 100% BP and a 1.00 BPP 
value, respectively.  
Morbillivirus phylogeny based on MV H protein sequences reflected the host grouping, 
except for MV. CDV (dogs, Baikal seals) and PDV (seals), and PMV (porpoises) and DMV 
(dolphins), respectively, formed single clades each with 100% BP and 1.00 BPP support 
(Figure 2(b)). The monophyletic lineage of MV (human) (100% BP and 1.00 BPP) was within 
the grouping of ruminant viruses, RPV (cow) and PPRV (sheep and goat), with 100% BP and 
1.00 BPP. These phylogenetic trees indicated that SLAMs and viral H proteins roughly co-
evolved. However, the monophyletic lineage of MV and the ruminant viruses RPV and 
PPRV suggested that human MV may have originated from ancestral RPV in cattle by 
acquiring a binding affinity for human SLAM, as proposed in a previous report based on the 
morbillivirus P gene [9] 
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ML analyses were performed using PhyML [72], and an input tree was generated using BIONJ with the JTT model [73] 
along with amino acid substitution that incorporated invariable sites and used a discrete gamma distribution (eight 
categories) (JTT + I + G model). Bayesian phylogenetic analyses were conducted using MrBayes version 3.0 within the 
JTT + I + G model [74]. The ML bootstrap probabilities and BPPs are shown at the nodes. Host animals and the 
corresponding morbilliviruses are shown as circles with the same alphabetic notations: A, cetaceans; B, artiodactyla; C, 
pinnipeds; D, dogs; E, primates; F, rodents; and G, manatees and elephants. Morbillivirus has not been identified in 
rodents (F), or manatees and elephants (G). The following SLAM gene sequences were obtained from the Data Bank of 
Japan: Pacific white-sided dolphin (AB428366); killer whale (AB428367); spotted seal (AB428368); walrus (AB428369); 
Indian elephant (AB428370); American manatee (AB428371); human beings (Homo sapiens, NM_003037); chimpanzee 
(Pan troglodytes, XM_513924); marmoset (Saguinus oedipus, AF257239); Rhesus monkey (Macaca mulatta, 
XM_001117605); cow (Bos taurus, AF329970); buffalo (Bubalus bubalis, DQ228868); sheep (Ovis aries, NM_001040288); 
goat (Capra hircus, DQ228869); dog (Canis familaris, AF325357); mouse (Mus musculus, NM_013730); and rat (Rattus 
norvegicus, XM_001054873). Morbillivirus H protein sequences were obtained as follows: MV Edmonston AIK-C strain 
(AB046218); MV V9301 strain (AB012948); MV B9301 strain (AB012949); RPV RBOK strain (Z30697); PPRV Turkey 2000 
strain (NC_006383); CDV Onderstepoort vaccine strain (AF305419); CDV Baikal seal strain (X84998); CDV 5804/Han90 
strain (X85000); PDV Ulster/88 strain (D10371); PMV 2990 strain (AY586537); and DMV (NC_005283). The alignments 
of the deduced amino acid sequences from these genes were generated using ClustalW version 1.8, inspected visually, 
and edited manually. This figure was adapted from [71]. 
Figure 2. Phylogenetic trees of SLAM peptide sequences (a) and morbillivirus H proteins (b).  
3.2.3. Three-dimensional models of marine mammal SLAM extracellular domain 
In order to analyze the binding site for morbillivirus, three-dimensional (3D) models of 
marine mammal SLAM extracellular domains were generated by homology modeling. 
Previously, we constructed 3D homology models based on the crystallographic structure of 
the human NTB-A molecule, a member of the SLAM family, as a template [71,75]. In the 
present study, we generated a new version of the models by adding the recently determined 
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crystal structure information of the bound complex of MV H and marmoset SLAM V [56]. 
Figure 3 shows the 3D model of the Pacific white-sided dolphin SLAM extracellular domain 
in a self-ligand form. In the models, the V and C2 domains are shown with rod-like 
structures, which are both constituted mainly of -sheets containing several -strands. The 
cysteine residues appear to be important in forming the basic 3D structures. On the basis of 
amino acid sequence similarity, this structure is shared with all of the SLAMs examined. The 
V domain possesses a two-layered -sheet structure, and the front sheets provide an 
interface for binding with morbilliviruses.  
 
In (a), the blue and green models show respective SLAM extracellular domains forming a homophilic dimer. The β-
strands are indicated by arrows and the disulfide bonds are shown as yellow bars. The thick red arrow indicates the 
direction of view of the front face of the morbillivirus binding site, as shown in Figure 4. In (b), the blue and black 
models indicate two SLAM molecules of two adjacent cells, respectively. The Protein Data Bank (PDB) entries for the 
marmoset SLAM in the complex (3ALW: A-D chains, 3ALX: A–D chains, 3ALZ: B chain; reference [56]) and for human 
NTB-A (21F7: A–D chains; reference [75]), were used as the template structure. The 3D model was constructed using 
the MODELLER 9.10 program [76] and visualized using PyMOL 1.4.1 (Schrodinger LLC) and PovRay (Persistence of 
Vision Pty. Ltd.). 
Figure 3. Ribbon diagram of the 3D structure (a) and schematic drawing (b) of the SLAM extracellular 
domain from the Pacific white-sided dolphin.  
Figure 4 shows top views of the front face of the modeled V domains of SLAMs of the 
spotted seal, Pacific white-sided dolphin, and West Indian manatee. The amino acid 
residues that have protruding side-chains on their front faces are likely a component of 
virus binding. We found such qualified 27 amino acid residues; 12 amino acid residues on 
the β-strands and 15 residues on loops (Figure 4). In addition, the amino acid residues 
positioned at 76, and the residues at 127-131 are thought to be important for the binding of 
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the virus, because the side-chains of these residues are closely located to those of viral H 
protein in a crystal structure of the complex [56]. Particularly, the residues at 127-131 are 
thought to form an intramolecular β-sheet with the β-strand of MV H [56]. The overall 3D 
structures of the interfaces are similar among SLAMs, but several among the total 32 amino 
acid residues possibly contributing the binding affinity to the virus, differed among the 
three marine mammals.  
 
The interfaces are viewed from the direction shown by the thick red arrow in Figure 3. The amino acid residues that 
possibly interact with the viral H protein, are shown with their position numbers. The different amino acid residues 
among the three mammal SLAMs are indicated in black, and their side-chains are shown with the atoms colored (black 
for carbons, blue for nitrogens, and red for oxygens). The shared residues among the three are shown in blue. Disulfide 
bonds are shown in yellow.  
Figure 4. Ribbon diagram of the 3D structure models of the SLAM interface for binding morbillivirus 
from the spotted seal (a), Pacific white-sided dolphin (b), and manatee (c).  
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3.2.4. Prediction of amino acid residues involved in virus binding and host–virus 
specificity 
To identify amino acid residues that are important for host–virus specificity, we compared 
the 32 residues with those of land mammal SLAMs (Table 2). The difference in the SLAM 
interface was only two amino acid residues between seal and dog (Val and Ile at position 74, 
and Arg and Gln at position 129), between human and marmoset (Leu and Phe at position 
119, Val and Ile at position 126, marmoset data not shown), and between cow and sheep 
(Asp and Gly at position 87, and Arg and His at position 90). This is consistent with the 
evidence that mass die-offs of Baikal seals and Caspian seals were caused by CDV; 
marmosets are highly sensitive to MV; and that RPV and PPRV can infect ruminants. It is 
noted that the identity of these 32 residues between dolphin and cow SLAMs is very high, 
although they are infected by different morbilliviruses, CMV and RPV, respectively. Four 
residues are different between the two animals, while eleven and fourteen residues are 
different between dolphin and seal, and between dolphin and humans, respectively.  
 
a.a. No. Seal Dog Dolphin Cow Sheep Human Manatee 
58 K K K K K K K 
60 I I I I I I I 
61 H H H H H H R* 
63 L L L L L V V 
65 T T T T T T T 
67 A A A A A A E* 
68 E E G* E E K* T* 
69 S S S S S S S 
72 N N D D D N S 
73 S S T T T S T 
74 V I V V V V F 
75 K K K K K E* K 
76 K K K K K N* K 
77 K K K K K K K 
80 S S S S S S S 
82 D D D D D D D 
84 P P R R R S S 
85 E E K K K E E 
87 G G D D G G G 
90 R R H R H R P* 
92 L L L L L L L 
117 W W W W W W W 
119 F F F F F L F 
121 T T S S S T T 
123 E E E E E E E 
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a.a. No. Seal Dog Dolphin Cow Sheep Human Manatee 
125 N N N N N N N 
126 F F I V V V F 
127 S S S S S S S 
128 V V V V V V V 
129 R* Q Q Q Q Q Q 
130 H H Q H H R Q 
131 F F F F F F F 
Viruses PDV, 
CDV 





The residue position, which varies among animals, is shaded. The light- and dark-shaded boxes indicate a variation in 
chemically (charge, hydrophilicity, etc.) similar or different residues. The asterisk indicates the specific residue with a 
chemical change for the animal SLAM. See the legend of Figure 2 for the animal names and accession numbers of the 
amino acid sequences used in this table. 
Table 2. Amino acid residues on the SLAM interface possibly involved in regulating the binding and 
specificity of morbilliviruses. 
Among the 32 residue positions, variations in amino acids were found at 18 positions (Table 
2, light and dark shading). At six positions (63,73,74,119,121, and 126), the changes are 
between chemically similar residues (light-shaded boxes in Table 2) and these do not seem 
to markedly affect binding with the viruses. On the other hand, the variations at the other 
twelve residue positions (61,67,68,72,75,76,84,85,87,90,129, and 130; dark-shaded boxes in 
Table 2) occur in amino acids with chemically different characteristics. In particular, the 
variations among amino acids with opposite charge may significantly alter the affinity for 
viruses (positions 68,75, and 85). The twelve amino acid residues are thought to be 
important in determining host–virus specificity. Almost of the twelve residues are located in 
the edge region of the interface. This may indicate that residues located in the central region 
of the interface play an important role in virus entry itself, rather than in host–virus 
specificity. Alternatively, they may be essential for a primary immunological function.  
A detailed binding assay using surface plasmon resonance analysis was carried out between 
human SLAM mutants and the MV H protein [56,57]. The respective changes in the residues 
from H61, E123, and R130 of the human SLAM interface to serine residues completely 
abolished the binding ability to the MV H protein. In crystallographic analysis, R130 was 
suggested to form an intramolecular salt bridge with E75 [56]. Only human SLAM possesses 
these two residues on the interface. As shown in Table 2, K68, a strong positively charged 
residue, is also specific for human SLAM. These facts suggest that they are key residues for 
MV infection. On the other hand, H61 and E123 are conserved in all mammals, except for 
R61 of manatees, suggesting that these residues play a crucial role in viral infection, rather 
than in host–virus specificity.  
Although a detailed analysis of SLAM–virus interaction has not been conducted in systems 
other than the human SLAM–MV complex, animal-specific residues can be seen in Table 2. 
For example, the markedly specific residue set R84-K85–D87-H90 is found in dolphin. These 
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residues are located spatially near each other in the 3D homology model of the interface 
(Figure 4). To clarify the influence of the changes in the charge, electrostatic potentials on the 
surface of SLAM interfaces of the three marine mammals, are shown in Figure 5. It can be 
seen that the zone constituted by the residues at positions 84, 85, 87, and 90 are different 






Electrostatic potential was calculated using DelPhi v.4 [77,78]. Positively and negatively charged surfaces are colored 
blue and red, respectively. 
Figure 5. Electrostatic potential on the surface of the SLAM interfaces with morbilliviruses deduced 
from the 3D homology model structures of the SLAM interfaces from the spotted seal (a), Pacific white-
sided dolphin (b), and manatee (c).  
The amino acid residues at positions 67 and 68 are also highly variable among the three 
interfaces (Table 2). The manatee-specific residue E67 appears to contribute greatly to the 
formation of the negatively charged zone (Figure 5). The manatee SLAM has two another 
specific residues, R61 and P90, which induce an acquisition of stronger positive charge or a 
loss of positive charge on the interface (Table 2, Figure 4). These findings suggest that if 
there is a morbillivirus for the sirenians, it has the H protein with a very different SLAM 
binding interface.  
Crystallographic analysis of the complex of MV H and marmoset SLAM V unexpectedly 
showed two different potentially tetramic configurations, form I and form II [56]. Residue 
N53 is located at the interface only in form II. Its replacement mutant changing to Q53 
showed a reduction in molecular masses, meaning the loss of glycosylation, and an 
unexpected increase in MV entry into human cells. The reason for this is not fully 
understood. However, because only primate and manatee SLAMs possess residue N53, it 
may also be involved in host–virus specificity. 
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4. Risk assessment of morbillivirus infection based on SLAM interface 
structures  
Human beings have a long history of diseases caused by morbilliviruses, which introduced 
devastating contagious diseases to humans and domestic animals. Since Jenner’s seminal 
discovery of the concept of immunity and vaccines, vaccines against various pathogens have 
been developed. By virtue of that great endeavor, an effective vaccine against measles is 
now available [79,80]. It has reduced measles deaths worldwide by 74% between 2000 and 
2010 (from 535,300 to 139,300), although measles is still a threat for children in developing 
countries [81]. Rinderpest induced by RPV, one of the oldest recorded livestock plagues, has 
been actually eradicated by the success of the Global Rinderpest Eradication Programme 
[82-84]. Thus, numerous efforts at eradication have achieved the control of human and 
domesticated animal diseases. Similar control of morbillivirus infections in wild animals 
will be one of the most important issues in the field of veterinary medicine in the 21st 
century. Marine mammals have large geographical ranges in the oceans. For example, 
baleen whales are known to migrate seasonally from the equator to the polar seas, 
indicating that they may be a dynamic vector for infectious diseases. In addition, recent 
global climate change may alter the ecology of marine mammals, such as their habitats, 
migration patterns, food, and behavior, and may increase opportunities for contact among 
previously geographically separate mammalian populations. These alterations may increase 
the possibility of viral transmission and the likelihood of outbreaks in susceptible 
mammalian populations.  
In viral infection, disease incidence, and transmission, several factors in host cells play a key 
role. In addition, ecological factors such as animal distribution, population structure and 
size, and behavior are decisive factors in actual infection. In the present study, we used a 
new approach to assess the potential infectivity of morbilliviruses based on receptor 
structure predictions. The residues on the interface of the SLAM V domain probably 
contribute to virus binding, and some residues among them are key for host–virus 
specificities. The analysis of these residues on 3D models of the SLAM receptor is useful for 
estimating the risk of morbillivirus infection in wild animals. This approach is applicable to 
animals for which no information on infection and disease. For the animals, it is possible to 
predict potential infection with known morbilliviruses. This may reveal possible infection 
spectra of morbilliviruses and suggest which mammals are reservoirs that maintain the 
viruses and how these viruses spread among wild mammals in nature.  
Control of infectious diseases in wild animals is very difficult. However, even though we 
cannot stop outbreaks from occurring in nature, information on the potential sensitivity of 
wild mammals against a virus may minimize the damage or prevent the spread of disease 
by such means as artificial transportation. Because marine mammals are positioned at the 
top of oceanic food chain, a decrease in marine mammal populations will affect marine 
ecosystems. We believe that the present study contributes to the conservation of marine 
mammals and their ecosystems. 
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5. Conclusion  
Morbillivirus, a member of the family Paramyxoviridae, is a causative agent of mass 
mortalities of marine mammals. To date, four virus species, MV, RPV, PPRV, and CDV have 
been identified in land mammals, and two virus species, PDV and CMV, have been 
identified in seals and cetaceans, respectively [4,47]. The notable biological feature of 
morbillivirus is its high level of host specificity. The cellular receptor for a virus is a major 
determinant of its host specificity and tissue tropism. SLAM is the principal cellular receptor 
for morbilliviruses allowing entry and propagation [18,19]. SLAM contains two 
immunoglobulin-like domains, the V and C2 domains, in the extracellular region. The 
morbillivirus H protein binds to the V domain on the target cells, which triggers viral 
infection [53] To assess the host–virus specificity of morbillivirus in marine mammals, we 
determined the complete nucleotide sequences of SLAM from five species belonging to 
cetaceans, pinippeds, and sirenians, and generated 3D homology models. The results 
showed that the overall structures are similar in the mammals examined. We found 32 
amino acid residues on the interface of SLAM V domain that are potentially involved in the 
interaction with viruses. Among them, a set of 18 amino acid residues is important for 
morbillivirus binding because some residues in the set differ among the mammal groups, 
which are susceptible to different morbillivirus species. A change in some residues in the set 
may cause an electrostatic change on the interface surface. These amino acid residues are 
thought to be important for host–virus specificity. 
Analysis of these residues on the interfaces of SLAMs will be useful to assess the risk of 
morbillivirus infection in wild animals. Recent climate change may increase the 
opportunities for new contacts among wild mammals and for the transmission of viruses. In 
the present study, we propose a new approach to assess the viral sensitivities of wild 
mammals by analyzing the host receptors. This approach will contribute to the conservation 
of wildlife including marine mammals and ecosystems. 
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